{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:47:45Z","timestamp":1792169265985,"version":"4.4.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2026,11,1]]},"abstract":"<jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>Despite the benefits of carbon fiber (CF) implants, concerns over their higher cost relative to titanium implants have limited their broader adoption in orthopaedic oncology. Our study compared the costs and postoperative complications associated with titanium and CF intramedullary nails (IMNs) in patients with femoral bone metastases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of patients treated with titanium or CF IMNs for impending or completed pathologic femoral fractures due to metastatic bone disease between 2016 and 2023. Inpatient costs, 30-day costs, and 30-day postoperative complications were assessed. Mean and median total, direct, and indirect costs were evaluated using cost units. Propensity-score matching was conducted to minimize potential confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      After propensity-score matching, we included 91 and 45 patients treated with titanium and CF femur IMNs, respectively. No differences in age, sex, primary tumor, or comorbidity profile were found between groups. Mean and median total costs, direct costs, and indirect costs during the inpatient stay and at 30 days postoperatively were similar between the titanium and CF groups. The mean length of stay was 8 days in both groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.70). Thirty-day complication rates were 25% and 20% in the titanium and CF group, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.50). No differences in 30-day readmission (25% in both;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.35), mortality (4% versus 9%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.29), and revision surgery (1% versus 2%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.61) rates were observed between the titanium and CF groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We found comparable inpatient costs, 30-day costs, and short-term postoperative complications between titanium and CF IMNs for impending or completed pathologic femoral fractures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>III<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-25-01176","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:22:17Z","timestamp":1779110537000},"page":"e3159-e3167","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Costs and Postoperative Complications Between Carbon Fiber and Titanium Intramedullary Nails in the Treatment of Impending or Completed Pathologic Femoral Fractures: A Propensity-Matched Study"],"prefix":"10.5435","volume":"34","author":[{"given":"Paul A.","family":"Rizk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos R.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlyn S.","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0681-9004","authenticated-orcid":false,"given":"Santiago A.","family":"Lozano-Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"R1-20261016","doi-asserted-by":"crossref","first-page":"e071674","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"key":"R2-20261016","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","article-title":"Precision treatment in advanced hepatocellular carcinoma","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"R3-20261016","doi-asserted-by":"crossref","first-page":"m3176","DOI":"10.1136\/bmj.m3176","article-title":"Emerging immunotherapies in multiple myeloma","volume":"370","author":"Shah","year":"2020","journal-title":"BMJ"},{"key":"R4-20261016","doi-asserted-by":"crossref","first-page":"100420","DOI":"10.1016\/j.jbo.2022.100420","article-title":"Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study","volume":"33","author":"Jakob","year":"2022","journal-title":"J Bone Oncol"},{"key":"R5-20261016","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1302\/2058-5241.1.000008","article-title":"Treatment of pathological fractures of the long bones","volume":"1","author":"Willeumier","year":"2016","journal-title":"EFORT Open Rev"},{"key":"R6-20261016","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/cncr.22991","article-title":"Pathologic fractures correlate with reduced survival in patients with malignant bone disease","volume":"110","author":"Saad","year":"2007","journal-title":"Cancer"},{"key":"R7-20261016","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2106\/JBJS.21.00711","article-title":"Clinical outcome differences in the treatment of impending versus completed pathological long-bone fractures","volume":"104","author":"Groot","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"R8-20261016","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00264-006-0205-9","article-title":"Treatment results of pathological fractures of the long bones: A retrospective analysis of 88 patients","volume":"30","author":"Sarahrudi","year":"2006","journal-title":"Int Orthop"},{"key":"R9-20261016","doi-asserted-by":"crossref","first-page":"102014","DOI":"10.1016\/j.suronc.2023.102014","article-title":"Femoral metastatic pathological fractures, impending and actual fractures - A patient survival study","volume":"51","author":"Hershkovich","year":"2023","journal-title":"Surg Oncol"},{"key":"R10-20261016","first-page":"393","article-title":"Management of long bones metastatic disease: Concepts that we all know but not always remember","volume":"14","author":"Gonzalez","year":"2022","journal-title":"Orthop Res Rev"},{"key":"R11-20261016","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0020-1383(17)30659-9","article-title":"Carbon-fiber reinforced intramedullary nailing in musculoskeletal tumor surgery: A national multicentric experience of the Italian Orthopaedic Society (SIOT) bone metastasis study group","volume":"48","author":"Piccioli","year":"2017","journal-title":"Injury"},{"key":"R12-20261016","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1302\/2633-1462.38.BJO-2022-0092.R1","article-title":"Comparison of carbon fibre and titanium intramedullary nails in orthopaedic oncology","volume":"3","author":"Yeung","year":"2022","journal-title":"Bone Jt Open"},{"key":"R13-20261016","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.5435\/JAAOS-D-22-01159","article-title":"Outcomes of long bones treated with carbon-fiber nails for oncologic indications: International multi-institutional study","volume":"32","author":"Lozano-Calder\u00f3n","year":"2024","journal-title":"J Am Acad Orthop Surg"},{"key":"R14-20261016","first-page":"e23.00222","article-title":"Patient-reported outcomes after intramedullary nailing of oncologic impending or pathologic fractures with carbon fiber or titanium implant","volume":"8","author":"Gonzalez","year":"2024","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"R15-20261016","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1530\/EOR-22-0001","article-title":"Intramedullary nailing for impending or pathologic fracture of the long bone: Titanium vs carbon fiber peek nailing","volume":"7","author":"Pala","year":"2022","journal-title":"EFORT Open Rev"},{"key":"R16-20261016","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1002\/cncr.22678","article-title":"Economic burden of metastatic bone disease in the U.S","volume":"109","author":"Schulman","year":"2007","journal-title":"Cancer"},{"key":"R17-20261016","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jso.27698","article-title":"Wound vacuum-assisted closure temporization after tumor resection of soft tissue sarcomas-A cost analysis in a propensity-score matched population","volume":"130","author":"Gonzalez","year":"2024","journal-title":"J Surg Oncol"},{"key":"R18-20261016","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s11999-016-4739-x","article-title":"Is prophylactic intervention more cost-effective than the treatment of pathologic fractures in metastatic bone disease?","volume":"474","author":"Blank","year":"2016","journal-title":"Clin Orthop Relat Res"},{"key":"R19-20261016","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2340\/17453674.2025.43479","article-title":"Hospital-related healthcare expenditure of impending versus completed pathological femur fractures: A propensity score matched study of 265 patients","volume":"96","author":"De Groot","year":"2025","journal-title":"Acta Orthop"},{"key":"R20-20261016","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R21-20261016","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1186\/s40064-016-3572-8","article-title":"The burden of metastatic disease of the femur on the medicare system","volume":"5","author":"Gendi","year":"2016","journal-title":"Springerplus"},{"key":"R22-20261016","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1097\/BOT.0000000000002320","article-title":"The use of carbon fiber implants for impending or existing pathologic fractures","volume":"36","author":"Herzog","year":"2022","journal-title":"J Orthop Trauma"},{"key":"R23-20261016","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.prro.2023.01.009","article-title":"Evaluation of carbon fiber and titanium surgical implants for proton and photon therapy","volume":"13","author":"Depauw","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"R24-20261016","first-page":"e2020057","article-title":"The advantages of carbon fiber based orthopedic devices in patients who have to undergo radiotherapy","volume":"91","author":"Soriani","year":"2020","journal-title":"Acta Biomed"},{"key":"R25-20261016","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/acm2.12046","article-title":"Perturbation effects of the carbon fiber-PEEK screws on radiotherapy dose distribution","volume":"18","author":"Nevelsky","year":"2017","journal-title":"J Appl Clin Med Phys"},{"key":"R26-20261016","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s10195-023-00724-4","article-title":"Carbon-fibre plates for traumatic and (impending) pathological fracture fixation: Where do we stand? A systematic review","volume":"24","author":"Rijs","year":"2023","journal-title":"J Orthop Traumatol"},{"key":"R27-20261016","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.jse.2023.04.023","article-title":"Titanium vs. carbon fiber-reinforced intramedullary nailing for humeral bone tumors","volume":"32","author":"Bhashyam","year":"2023","journal-title":"J Shoulder Elbow Surg"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:00:54Z","timestamp":1792166454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":27,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-25-01176","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"2025-09-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}